文献速递间质性肺疾病

欧洲裔人群特发性肺纤维化易感性的全基因组关联研究

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
PubMed 文献 · Lancet Respir Med · 2017-10-20

易感等位基因还与小气道组织中AKAP13 mRNA表达升高相关。

要点

  • 该位点易感等位基因与肺组织AKAP13 mRNA表达升高相关。
  • MUC5B和DSP的已知关联在独立样本中得到验证。

核心结论

  • AKAP13是IPF新的易感基因,其编码的Rho鸟苷酸交换因子调控RhoA活化,为靶向RhoA通路抑制剂提供了依据。

研究设计与样本

  • 两阶段设计:阶段1为英国9个中心招募的欧洲裔IPF患者602例与UK Biobank对照3366例(按年龄、性别和吸烟状态匹配)的全基因组关联研究。
  • 阶段2为美国芝加哥和科罗拉多两个独立样本中IPF患者2158例与对照5195例的关联信号随访验证。
  • 利用转录组和基因组数据资源分析新信号对基因表达的影响,并在IPF患者与对照肺组织样本中检测表达。

主要发现

  • rs62025270的A等位基因与肺切除患者(n=1111)肺组织中AKAP13 mRNA表达升高相关。

临床怎么用

  • AKAP13作为IPF易感基因的发现提示RhoA通路抑制剂可能成为IPF的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with high mortality, uncertain cause, and few treatment options. Studies have identified a significant genetic risk associated with the development of IPF; however, mechanisms by which genetic risk factors promote IPF remain unclear. We aimed to identify genetic variants associated with IPF susceptibility and provide mechanistic insight using gene and protein expression analyses. METHODS: We used a two-stage approach: a genome-wide association study in patients with IPF of European ancestry recruited from nine different centres in the UK and controls selected from UK Biobank (stage 1) matched for age, sex, and smoking status; and a follow-up of associated genetic variants in independent datasets of patients with IPF and controls from two independent US samples from the Chicago consortium and the Colorado consortium (stage 2). We investigated the effect of novel signals on gene expression in large transcriptomic and genomic data resources, and examined expression using lung tissue samples from patients with IPF and controls. FINDINGS: 602 patients with IPF and 3366 controls were selected for stage 1. For stage 2, 2158 patients with IPF and 5195 controls were selected. We identified a novel genome-wide significant signal of association with IPF susceptibility near A-kinase anchoring protein 13 (AKAP13; rs62025270, odds ratio [OR] 1·27 [95% CI 1·18-1·37], p=1·32 × 10-9) and confirmed previously reported signals, including in mucin 5B (MUC5B; rs35705950, OR 2·89 [2·56-3·26], p=1·12 × 10-66) and desmoplakin (DSP; rs2076295, OR 1·44 [1·35-1·54], p=7·81 × 10-28). For rs62025270, the allele A associated with increased susceptibility to IPF was also associated with increased expression of AKAP13 mRNA in lung tissue from patients who had lung resection procedures (n=1111). We showed that AKAP13 is expressed in the alveolar epithelium and lymphoid follicles from patients with IPF, and AKAP13 mRNA expression was 1·42-times higher in lung tissue from patients with IPF (n=46) than that in lung tissue from controls (n=51). INTERPRETATION: AKAP13 is a Rho guanine nucleotide exchange factor regulating activation of RhoA, which is known to be involved in profibrotic signalling pathways. The identification of AKAP13 as a susceptibility gene for IPF increases the prospect of successfully targeting RhoA pathway inhibitors in patients with IPF. FUNDING: UK Medical Research Council, National Heart, Lung, and Blood Institute of the US National Institutes of Health, Agencia Canaria de Investigación, Innovación y Sociedad de la Información, Spain, UK National Institute for Health Research, and the British Lung Foundation.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Allen RJ, Porte J, Braybrooke R, et al. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir Med. 2017. PMID: 29066090. doi:10.1016/S2213-2600(17)30387-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。